Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burden*

Authors

  • S.M.C.H. Langenberg Department of Medical Oncology, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands
  • A.K.L Reyners Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
  • A.N.M. Wymenga Department of Medical Oncology, Medical Spectrum Twente, Enschede, The Netherlands
  • G.C.M. Sieling Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
  • C.M.M Veldhoven Department of Pain and palliatieve care, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands;  General practitioner Berg en Dal, Nijmegen, The Netherlands
  • C.M.L. van Herpen Department of Medical Oncology, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands
  • J.B. Prins Department of Medical Psychology, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands
  • W.T.A. van der Graaf Department of Medical Oncology, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands;  Division of Clinical Studies, The Institute of Cancer Research & the Sarcoma Unit, Royal Marsden Hospital, London, UK

DOI:

https://doi.org/10.1080/0284186X.2018.1518592

Abstract

Background: TKIs are a long-term treatment for GIST, and may have an impact on caregivers.

Material and Methods: For this cross-sectional study, patients and caregivers were both included when patients had been treated with TKIs for at least six months. Caregivers completed questionnaires including demographics, distress (Hospital Anxiety and Depression scale), burden (Self-Perceived Pressure from Informal Care) general health (RAND-36), comorbidity (Self-administered Comorbidity Questionnaire), social support (Social Support List – Discrepancies) and marital satisfaction (Maudsley Marital Questionnaire). Patients completed similar questionnaires, without ‘burden’. We conducted analyses to explore differences between caregivers with low/moderate versus high levels of burden and low versus high levels of distress.

Results: Sixty-one out of seventy-one eligible couples (84%) were included in the analysis. The median age of the caregivers was 60 years; 66% were female and 78% were the patients’ spouse. The median age of the patients was 66 years; 43% were female. Caregivers experienced high levels of burden and distress in 10% and 23%, respectively. Caregivers with high levels of burden perceived significantly lower mental health, less vitality, lower general health and high levels of distress. Significantly higher levels of burden were found in non-spouses, caregivers of patients with more treatment-related side-effects, caregivers who spent more hours caring, and those caring for more than one person. For distress, caregivers with high levels of distress perceived significantly more burden, lower social functioning, more role physical and emotional problems, lower mental health, less vitality and lower general health. Furthermore, high levels of distress were found in caregivers of more dependent patients and those caring for more than one person.

Conclusions: Caregivers of the patients with GIST treated with TKI are managing well. There is a small, vulnerable group of caregivers with high levels of burden and/or distress, show more health-related problems, both physical and mental, and require adequate support.

Downloads

Download data is not yet available.

Downloads

Published

2019-02-01

How to Cite

Langenberg, S., Reyners, A., Wymenga, A., Sieling, G., Veldhoven, C., van Herpen, C., … van der Graaf, W. (2019). Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burden*. Acta Oncologica, 58(2), 191–199. https://doi.org/10.1080/0284186X.2018.1518592